RXRX

#2015
Recursion Pharmaceuticals, Inc. Class A Common Stock
3.53 USD
+3.22%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
3.50
3.53
Rango anual
2.80
7.18
Cambio diario
+3.22%
Variación mensual
+2.32%
Variación en los últimos 6 meses
-41.46%
Cambio anual
-36.40%
Cierres anteriores
3.42
Abrir
3.50
Bid
Ask
Mínimo
3.50
High
3.53
Volumen
964
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.86 B
  • Employee 600
  • Founded 2013
  • CEO Najat Khan
  • Website www.recursion.com
  • Headquarter Delaware, United States
  • FIGI BBG00PQ4XJ45
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.84
Relación precio/flujo de caja
24.5

Recursion Pharmaceuticals Inc - Class A

Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.

Noticias